These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 33973224)

  • 1. [Molecular pathology - the key to precision oncology].
    Edsjö A; Palmqvist R; Haglund F; Helenius G; Lindqvist O; Fagman H; Botling J
    Lakartidningen; 2021 May; 118():. PubMed ID: 33973224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Genomic Medicine Sweden - a national initiative for the broad introduction of precision medicine in Swedish healthcare].
    Edsjö A; Friedman M; Rosenquist R
    Lakartidningen; 2021 May; 118():. PubMed ID: 33977514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A 2015 update on predictive molecular pathology and its role in targeted cancer therapy: a review focussing on clinical relevance.
    Dietel M; Jöhrens K; Laffert MV; Hummel M; Bläker H; Pfitzner BM; Lehmann A; Denkert C; Darb-Esfahani S; Lenze D; Heppner FL; Koch A; Sers C; Klauschen F; Anagnostopoulos I
    Cancer Gene Ther; 2015 Sep; 22(9):417-30. PubMed ID: 26358176
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Molecular-Genetic Diagnosis and Molecular-Targeted Therapy in Cancer: Challenges in the Era of Precision Medicine].
    Miyachi H
    Rinsho Byori; 2015 Oct; 63(10):1188-93. PubMed ID: 26897855
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trailblazing precision medicine in Europe: A joint view by Genomic Medicine Sweden and the Centers for Personalized Medicine, ZPM, in Germany.
    Stenzinger A; Edsjö A; Ploeger C; Friedman M; Fröhling S; Wirta V; Seufferlein T; Botling J; Duyster J; Akhras M; Thimme R; Fioretos T; Bitzer M; Cavelier L; Schirmacher P; Malek N; Rosenquist R;
    Semin Cancer Biol; 2022 Sep; 84():242-254. PubMed ID: 34033893
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Precision diagnostics: integration of tissue pathology and genomics in cancer.
    Sharma S; George P; Waddell N
    Pathology; 2021 Dec; 53(7):809-817. PubMed ID: 34635323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular profiling for personalized cancer care.
    Ashfaq R
    Clin Exp Metastasis; 2012 Oct; 29(7):653-5. PubMed ID: 22678423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conceptual framework for precision cancer medicine in Germany: Consensus statement of the Deutsche Krebshilfe working group 'Molecular Diagnostics and Therapy'.
    Westphalen BC; Bokemeyer C; Büttner R; Fröhling S; Gaidzik VI; Glimm H; Hacker UT; Heinemann V; Illert AL; Keilholz U; Kindler T; Kirschner M; Schilling B; Siveke JT; Schroeder T; Tischler V; Wagner S; Weichert W; Zips D; Loges S;
    Eur J Cancer; 2020 Aug; 135():1-7. PubMed ID: 32521293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular predictive testing in precision oncology: The Italian experience.
    Vigliar E; Iaccarino A; Sciortino M; De Luca C; Malapelle U; Bellevicine C; Troncone G
    Cancer Cytopathol; 2020 Sep; 128(9):622-628. PubMed ID: 32885914
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular diagnostics tailoring personalized cancer therapy-an oncologist's view.
    Riedl JM; Moik F; Esterl T; Kostmann SM; Gerger A; Jost PJ
    Virchows Arch; 2024 Feb; 484(2):169-179. PubMed ID: 37982847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An Approach to Solving the Complex Clinicogenomic Data Landscape in Precision Oncology: Learnings From the Design of WAYFIND-R, a Global Precision Oncology Registry.
    Le Tourneau C; Perret C; Hackshaw A; Blay JY; Nabholz C; Geissler J; Do T; von Meyenn M; Dienstmann R
    JCO Precis Oncol; 2022 Jul; 6():e2200019. PubMed ID: 35939770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Personalized oncology: recent advances and future challenges.
    Kalia M
    Metabolism; 2013 Jan; 62 Suppl 1():S11-4. PubMed ID: 22999010
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Precision Oncology and "Molecular Tumor Boards" - Concepts, Chances and Challenges].
    Holch JW; Westphalen CB; Hiddemann W; Heinemann V; Jung A; Metzeler KH
    Dtsch Med Wochenschr; 2017 Nov; 142(22):1676-1684. PubMed ID: 29078213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Real-World Data on NGS Diagnostics: a survey from the Italian Society of Pathology (SIAPeC) NGS Network.
    Marchetti A; Barbareschi M; Barberis M; Buglioni S; Buttitta F; Fassan M; Fontanini G; Marchiò C; Papotti M; Pruneri G; Scarpa A; Stanta G; Tallini G; Troncone G; Veronese SM; Truini M; Sapino A
    Pathologica; 2021 Aug; 113(4):262-271. PubMed ID: 34463674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The clinical trial landscape in oncology and connectivity of somatic mutational profiles to targeted therapies.
    Patterson SE; Liu R; Statz CM; Durkin D; Lakshminarayana A; Mockus SM
    Hum Genomics; 2016 Jan; 10():4. PubMed ID: 26772741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An overview of the NCI precision medicine trials-NCI MATCH and MPACT.
    Do K; O'Sullivan Coyne G; Chen AP
    Chin Clin Oncol; 2015 Sep; 4(3):31. PubMed ID: 26408298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. National Cancer Institute's Precision Medicine Initiatives for the new National Clinical Trials Network.
    Abrams J; Conley B; Mooney M; Zwiebel J; Chen A; Welch JJ; Takebe N; Malik S; McShane L; Korn E; Williams M; Staudt L; Doroshow J
    Am Soc Clin Oncol Educ Book; 2014; ():71-6. PubMed ID: 24857062
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Building a precision medicine infrastructure at a national level: The Swedish experience.
    Edsjö A; Lindstrand A; Gisselsson D; Mölling P; Friedman M; Cavelier L; Johansson M; Ehrencrona H; Fagerqvist T; Strid T; Lovmar L; Jacobsson B; Johansson Å; Engstrand L; Wheelock CE; Sikora P; Wirta V; Fioretos T; Rosenquist R;
    Camb Prism Precis Med; 2023; 1():e15. PubMed ID: 38550923
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Path toward Precision Oncology: Review of Targeted Therapy Studies and Tools to Aid in Defining "Actionability" of a Molecular Lesion and Patient Management Support.
    Chae YK; Pan AP; Davis AA; Patel SP; Carneiro BA; Kurzrock R; Giles FJ
    Mol Cancer Ther; 2017 Dec; 16(12):2645-2655. PubMed ID: 29203694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Personalization of Therapy: Molecular Profiling Technologies and Their Application.
    Zeron-Medina J; Ochoa de Olza M; Braña I; Rodon J
    Semin Oncol; 2015 Dec; 42(6):775-87. PubMed ID: 26615125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.